Best Cards to Grade in Facing a New Trial
17 Facing a New Trial cards ranked by grading ROI. Wailord 016/49 leads at 8.1x ($4.45 raw vs $305.00 in PSA 10). Live prices, PSA gem rates and population.
ROI is the PSA 10 price against the raw price plus grading cost and PSA's value-tier upcharge, from live market prices and PSA population data. Cards are ranked highest ROI first.
| Rank | Card | Raw | PSA 10 | Gem rate | PSA 10 pop | ROI |
|---|---|---|---|---|---|---|
| 1 | Wailord 016/49 | $4.45 | $305.00 | 73.3% | 22 | 8.1x |
| 2 | Slowking 023/49 | $5.00 | $152.50 | 86.5% | 109 | 4.0x |
| 3 | Darkrai GX 055/49 | $40.00 | $195.50 | 67.7% | 111 | 2.7x |
| 4 | Slowpoke 022/49 | $12.00 | $118.50 | 83.7% | 144 | 2.6x |
| 5 | Sophocles 057/49 | $61.38 | $239.00 | 56.7% | 186 | 2.5x |
| 6 | Alolan Sandshrew 011/49 | $5.00 | $90.47 | 81.5% | 22 | 2.4x |
| 7 | Acerola 056/49 | $2,397.19 | $7,000.00 | 32.4% | 567 | 2.3x |
| 8 | Komala 043/49 | $0.98 | $61.26 | 100.0% | 1 | 1.8x |
| 9 | Sableye 039/49 | $2.00 | $55.42 | 83.3% | 20 | 1.6x |
| 10 | Wailmer 015/49 | $1.25 | $50.23 | 83.3% | 5 | 1.5x |
7 more Facing a New Trial cards are ranked for Pro members.